Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical group purchasing cuts costs, expands knowledge

A G Lipman, E P Bauer

    Hospitals
    |April 16, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits.

    Neuroscience·2013
    Same author

    A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment.

    Translational psychiatry·2013
    Same author

    Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain.

    Neurogastroenterology and motility·2010
    Same author

    Pre- and postoperative assessment of left ventricular function by magnetic resonance imaging and 2-D-echocardiography in patients undergoing left ventricular aneurysmectomy.

    The Thoracic and cardiovascular surgeon·2004
    Same author

    Drug therapy for delirium in terminally ill patients.

    The Cochrane database of systematic reviews·2004
    Same author

    Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: a systematic review of efficacy, side effects, and regulatory issues.

    Pain medicine (Malden, Mass.)·2004
    Same journal

    The hospital and education.

    Hospitals·2014
    Same journal

    Three guides to finding a good architect.

    Hospitals·2010
    Same journal

    Who will pay hospital bills for postwar patients?

    Hospitals·2010
    Same journal

    DEVELOPING a rural community hospital.

    Hospitals·2010
    Same journal

    Personnel organization no substitute for good personnel relations.

    Hospitals·2010
    Same journal

    Neonatal crying; a study of its incidence, causes and control.

    Hospitals·2010
    See all related articles

    The Connecticut Hospital Association (CHA) CSHP group purchasing program offers significant cost savings and drug information sharing for hospitals. This pharmacist-led initiative ensures excellent industry participation and fair cost distribution among members.

    Area of Science:

    • Health Services Research
    • Pharmaceutical Management
    • Hospital Administration

    Background:

    • Group purchasing organizations (GPOs) are common in healthcare to leverage collective buying power.
    • Effective pharmaceutical procurement is crucial for hospital cost containment and operational efficiency.
    • The Connecticut Hospital Association (CHA) established the CSHP program to address pharmaceutical purchasing needs.

    Purpose of the Study:

    • To evaluate the benefits and operational success of the CHA-CSHP pharmaceutical group purchasing program.
    • To assess the program's impact on cost savings and information sharing among participating hospitals.

    Main Methods:

    • Program analysis focusing on operational structure and participant engagement.
    • Evaluation of pharmaceutical industry participation through bid invitation strategies.

    Related Experiment Videos

  • Assessment of cost-sharing mechanisms and their impact on hospital contributions.

    • Main Results:

    • High pharmacist compliance due to significant input in program decisions.
    • Excellent pharmaceutical industry participation driven by transparent purchasing data.
    • Self-supporting program structure preventing larger hospitals from disproportionately subsidizing costs.

    Conclusions:

    • The CHA-CSHP program successfully delivers substantial cost savings to member hospitals.
    • The program facilitates valuable drug information sharing among healthcare institutions.
    • Pharmacist involvement and transparent industry engagement are key success factors.